These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 34170959)
1. Systemic complement activation levels in Stargardt disease. Dhooge PPA; Runhart EH; Li CHZ; de Kat Angelino CM; Hoyng CB; van der Molen RG; den Hollander AI PLoS One; 2021; 16(6):e0253716. PubMed ID: 34170959 [TBL] [Abstract][Full Text] [Related]
2. Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease. Lenis TL; Sarfare S; Jiang Z; Lloyd MB; Bok D; Radu RA Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3987-3992. PubMed ID: 28348233 [TBL] [Abstract][Full Text] [Related]
3. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792 [TBL] [Abstract][Full Text] [Related]
4. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels. Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670 [TBL] [Abstract][Full Text] [Related]
5. Impaired cathepsin D in retinal pigment epithelium cells mediates Stargardt disease pathogenesis. Ng ESY; Hu J; Jiang Z; Radu RA FASEB J; 2024 Jun; 38(11):e23720. PubMed ID: 38837708 [TBL] [Abstract][Full Text] [Related]
6. Cell-Type-Specific Complement Profiling in the ABCA4 Jabri Y; Biber J; Diaz-Lezama N; Grosche A; Pauly D Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187113 [TBL] [Abstract][Full Text] [Related]
7. Membrane Attack Complex Mediates Retinal Pigment Epithelium Cell Death in Stargardt Macular Degeneration. Ng ESY; Kady N; Hu J; Dave A; Jiang Z; Pei J; Gorin MB; Matynia A; Radu RA Cells; 2022 Nov; 11(21):. PubMed ID: 36359858 [TBL] [Abstract][Full Text] [Related]
8. High-Resolution Adaptive Optics in Vivo Autofluorescence Imaging in Stargardt Disease. Song H; Rossi EA; Yang Q; Granger CE; Latchney LR; Chung MM JAMA Ophthalmol; 2019 Jun; 137(6):603-609. PubMed ID: 30896765 [TBL] [Abstract][Full Text] [Related]
9. Zinc supplementation inhibits complement activation in age-related macular degeneration. Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287 [TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration. Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083 [TBL] [Abstract][Full Text] [Related]
11. Local and systemic activation of the whole complement cascade in human leukocytoclastic cutaneous vasculitis; C3d,g and terminal complement complex as sensitive markers. Dauchel H; Joly P; Delpech A; Thomine E; Sauger F; Le Loet X; Lauret P; Tron F; Fontaine M; Ripoche J Clin Exp Immunol; 1993 May; 92(2):274-83. PubMed ID: 8485913 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration. Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093 [TBL] [Abstract][Full Text] [Related]
14. Complement activation in bronchial asthma evaluated by the C3d/C3 index. Michel O; Sergysels R; Duchateau J Ann Allergy; 1986 Dec; 57(6):405-8. PubMed ID: 3491553 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus. Li J; An L; Zhang Z Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509 [TBL] [Abstract][Full Text] [Related]
16. Factors Influencing Retinal Pigment Epithelium-Atrophy Progression Rate in Stargardt Disease. Cicinelli MV; Rabiolo A; Brambati M; Viganò C; Bandello F; Battaglia Parodi M Transl Vis Sci Technol; 2020 Jun; 9(7):33. PubMed ID: 32832238 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration. Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS Ophthalmologica; 2020; 243(3):195-206. PubMed ID: 31743906 [TBL] [Abstract][Full Text] [Related]
18. Iron-induced Local Complement Component 3 (C3) Up-regulation via Non-canonical Transforming Growth Factor (TGF)-β Signaling in the Retinal Pigment Epithelium. Li Y; Song D; Song Y; Zhao L; Wolkow N; Tobias JW; Song W; Dunaief JL J Biol Chem; 2015 May; 290(19):11918-34. PubMed ID: 25802332 [TBL] [Abstract][Full Text] [Related]
19. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus. Senaldi G; Makinde VA; Vergani D; Isenberg DA Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693 [TBL] [Abstract][Full Text] [Related]
20. Complement Activation Levels Are Related to Disease Stage in AMD. Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]